Evidence based advice is provided on all smoking cessation strategies including:
- Therapeutic Goods Administration (TGA) approved pharmacotherapies
- behavioural interventions
- use of nicotine vaping products.
Also included is advice for clinicians on promoting the key benefits of smoking cessation to their patients, including the effects on physical and mental health and risks to the developing brain.
The RANZCP supports the legalisation and regulation of nicotine-containing e-cigarettes and other vaporised nicotine products to facilitate their use as harm reduction tools.
Endorsed external guidance
RANZCP e-learning module
►Smoking Cessation for Mental Health Clinicians [Member sign-in required]
Smoking cessation and vaping webinar
The management of tobacco smoking is one of the most important activities a mental health clinician can undertake to reduce mortality, improve quality of life and increase the efficacy of mental health treatment. This podcast examines the barriers, myths and evidence-based treatments for people who are dependent on tobacco.
Features Associate Professor Mat Coleman, Professor Sharon Lawn, Associate Professor John Allan, Dr Tanya Ahmed and Dr Kelly Ridley.
Rates of smoking in people with mental illness remain stubbornly high while rates in the general population continue to drop. This podcast discusses the place of e-cigarettes in reducing tobacco-related harm to people with mental illness.
Features Associate Professor Mat Coleman, Professor Hayden McRobbie and Dr Mark Montebello.
These resources have been produced by the RANZCP with financial support from the Australian Government through the Department of Health. The information contained herein may include the views or recommendations of third parties, which do not necessarily reflect the views of the Commonwealth, or indicate its commitment to a particular course of action.